ALKBH3 and adenocarcinoma: The presence and percentage of ALKBH3-positive cells might offer a meaningful way to predict/detect cancer recurrence at an earlier stage; moreover, targeting therapy to the ALKBH3 gene might markedly improve the clinical outcome for patients with adenocarcinoma.